Retatrutide Wholesale Supplier for Research Use
LotusBio supports laboratories, distributors and qualified research buyers seeking Retatrutide wholesale supply. Review Retatrutide in 5 mg, 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg and 100 mg formats, then select the catalog code and pack specification for your inquiry. Our team confirms current availability, batch documentation and destination requirements.
Build your inquiry
Availability, packaging and pricing are confirmed by our team.Retatrutide specifications and packaging
| Catalog code | Product / composition | Pack specification |
|---|---|---|
| RT5 | Retatrutide | 5 mg × 10 vials |
| RT10 | Retatrutide | 10 mg × 10 vials |
| RT15 | Retatrutide | 15 mg × 10 vials |
| RT20 | Retatrutide | 20 mg × 10 vials |
| RT30 | Retatrutide | 30 mg × 10 vials |
| RT40 | Retatrutide | 40 mg × 10 vials |
| RT50 | Retatrutide | 50 mg × 10 vials |
| RT60 | Retatrutide | 60 mg × 10 vials |
| RT100 | Retatrutide | 100 mg × 10 vials |
Each listed pack contains 10 vials. Select the catalog code and specification above, then add your box quantity to the inquiry.
Retatrutide wholesale supply for laboratories and distributors
For qualified research procurement, LotusBio supports Retatrutide wholesale inquiries across multiple vial specifications. Buyers can request current availability, batch documentation, COA information, packaging details and quotation terms before confirming an order.
Retatrutide documentation
Contact our team to request the available COA and confirm documentation for your specification and proposed supply batch.
Request COA →Retatrutide purchasing details
Select the catalog format
Keep RT codes separate from TR codes when preparing a multi-product request. RT20 identifies the 20 mg Retatrutide vial format; TR20 belongs to Tirzepatide.
Quantity example: RT20 lists 20 mg per vial and 10 vials per box. An inquiry for 2 boxes means 20 vials at 20 mg each. These are catalog label quantities, not batch assay results.
Vials or bulk raw material?
The quote selector on this page uses boxes of finished vials. For Retatrutide raw-material requirements, specify the required total mass, material specification and container requirements separately; the vial pack does not establish a raw-material minimum order quantity.
Documents and quotation scope
Ask for the complete material specification, including sequence and modifications, and documents linked to the proposed batch. Use the COA review checklist to record the product, batch and test scope.
Send the selected code, box count, destination country and requested delivery date. Ask the quote to confirm availability, minimum quantity, preparation time, shipping service and cost. If custom labels or boxes are needed, include them in the packaging inquiry. Delivery timing and batch documents are confirmed for the proposed order. The supplier checklist covers the wider purchasing review.
Retatrutide sourcing resources
Read the Retatrutide wholesale sourcing guide for procurement and documentation planning. For bulk API or raw-material requirements, use the Retatrutide API supplier page.
Related catalog products
PRODUCT IDENTITY & REFERENCE
Retatrutide: modified peptide identity
Retatrutide is also identified in the research literature as LY3437943. It is a modified peptide with a lipid-bearing side chain; the complete identity includes the peptide sequence, non-standard residues, attachment site and linker.
- Reference formula
- C221H342N46O68
- Reference molecular weight
- 4731 g/mol
- Reference record
- PubChem CID 171390338 ↗
This CID is currently titled Triple G in PubChem. The linked IUPHAR/BPS substance record associates it with retatrutide. Use the complete sequence and modifications when comparing supplied material.
Sequence notation matters
A one-letter sequence can omit the chemistry of non-standard residues and side-chain modifications. When comparing a proposed material with a published reference, request an explicit residue-by-residue specification and the full modification description. Similar names or an equal nominal mass do not establish identical structures.
What to confirm for this catalog item
Use RT catalog codes for the pack sizes above. Match the structural specification to batch identity data, and review purity and measured vial content as separate results.
Images and numerical properties describe the cited database forms, not batch test results. Confirm the actual supplied form against the specification. Molecular weights retain the precision reported by PubChem.
Reference sources
Related product details: Tirzepatide · Semaglutide
Reference review: 28 September 2026. Pack details follow the catalog above; batch information is confirmed separately.